A study of bioequivalence between HD201 and trastuzumab sourced in the European Union (EU-trastuzumab)
Phase of Trial: Phase I
Latest Information Update: 08 Mar 2018
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer; Gastric cancer
- Focus First in man; Pharmacokinetics
- 08 Mar 2018 New trial record
- 01 Mar 2018 Primary endpoint (AUC0-infinity) has been met as per the results published in the Clinical Therapeutics.
- 01 Mar 2018 Results assessing bioequivalence published in the Clinical Therapeutics.